Space & Aerospace
Novartis ends BioArctic pact; Two VC firms raise inaugural funds
Plus news about Teva, Ultragenyx and Specific Biologics. Novartis cans BioArctic collab: The Swiss pharma axed its discovery-stage work with the Swedish biotech, which created the Alzheimer’s drug Leqembi. The neurodegeneration-focused ...
Plus news about Teva, Ultragenyx and Specific Biologics. Novartis cans BioArctic collab: The Swiss pharma axed its discovery-stage work with the Swedish biotech, which created the Alzheimer’s drug Leqembi. The neurodegeneration-focused ...
This is a summary of the story. Read the full article at Endpoints News (Biopharma) ↗